4basebio UK Societas (GB:4BB)
LSE:4BB
Want to see GB:4BB full AI Analyst Report?
Total Valuation
4basebio UK Societas has a market cap or net worth of £81.30M. The enterprise value is 80.00M .
Market Cap£81.30M
Enterprise Value80.00M
Share Statistics
4basebio UK Societas has 15,538,518 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,538,518
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
4basebio UK Societas’s return on equity (ROE) is -1.67 and return on invested capital (ROIC) is -59.74%.
Return on Equity (ROE)-1.67
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-59.74%
Return on Capital Employed (ROCE)-0.63
Revenue Per Employee16.76K
Profits Per Employee-167.38K
Employee Count101
Asset Turnover0.06
Inventory Turnover1.74
Valuation Ratios
The current PE Ratio of 4basebio UK Societas is ―. 4basebio UK Societas’s PEG ratio is -0.35.
PE Ratio―
PS Ratio56.33
PB Ratio9.43
Price to Fair Value9.43
Price to FCF-6.27
Price to Operating Cash Flow-5.53
PEG Ratio-0.35
Income Statement
In the last 12 months, 4basebio UK Societas had revenue of 1.69M and earned -16.91M in profits. Earnings per share was -1.09.
Revenue1.69M
Gross Profit548.00K
Operating Income-16.73M
Pretax Income-17.60M
Net Income-16.91M
EBITDA-15.58M
Earnings Per Share (EPS)-1.09
Cash Flow
In the last 12 months, operating cash flow was -14.75M and capital expenditures -458.00K, giving a free cash flow of -15.21M billion.
Operating Cash Flow-14.75M
Free Cash Flow-15.21M
Free Cash Flow per Share-0.98
Dividends & Yields
4basebio UK Societas pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.24
52-Week Price Change-46.70%
50-Day Moving Average497.85
200-Day Moving Average625.14
Relative Strength Index (RSI)58.21
Average Volume (3m)999.00
Important Dates
4basebio UK Societas upcoming earnings date is Sep 25, 2026, Before Open (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateSep 25, 2026
Ex-Dividend Date―
Financial Position
4basebio UK Societas as a current ratio of 7.31, with Debt / Equity ratio of 163.24%
Current Ratio7.31
Quick Ratio7.07
Debt to Market Cap0.17
Net Debt to EBITDA0.08
Interest Coverage Ratio-18.86
Taxes
In the past 12 months, 4basebio UK Societas has paid -698.00K in taxes.
Income Tax-698.00K
Effective Tax Rate0.04
Enterprise Valuation
4basebio UK Societas EV to EBITDA ratio is -6.04, with an EV/FCF ratio of -6.19.
EV to Sales55.57
EV to EBITDA-6.04
EV to Free Cash Flow-6.19
EV to Operating Cash Flow-6.38
Balance Sheet
4basebio UK Societas has £17.80M in cash and marketable securities with £16.50M in debt, giving a net cash position of £1.30M billion.
Cash & Marketable Securities£17.80M
Total Debt£16.50M
Net Cash£1.30M
Net Cash Per Share£0.08
Tangible Book Value Per Share£0.34
Margins
Gross margin is -10.10%, with operating margin of -988.01%, and net profit margin of -998.52%.
Gross Margin-10.10%
Operating Margin-988.01%
Pretax Margin-1039.75%
Net Profit Margin-998.52%
EBITDA Margin-920.38%
EBIT Margin-988.01%
Analyst Forecast
The average price target for 4basebio UK Societas is £1,400.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£1,400.00
Price Target Upside127.64% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast81.46%
EPS Growth Forecast-15.88%